A large study in Hong Kong analyzed over 700,000 mother-child pairs and found no link between prenatal acetaminophen (Tylenol) use and autism or ADHD. The sibling-matched design controlled for genetic and environmental factors, refuting claims made by President Trump and Robert F. Kennedy Jr.
The Trump administration announced Thursday that medical marijuana will be moved from Schedule I to Schedule III, a category shared with Tylenol with codeine and anabolic steroids. Acting Attorney General Todd Blanche said the change allows for research on safety and efficacy, providing patients better care. The rescheduling applies only to FDA-approved and state-regulated medical marijuana products. Cannabis businesses in state medical programs would receive tax relief under Section 280E, and researchers would no longer need Schedule I licenses. The DEA will hold hearings on broader rescheduling on June 29.
The Trump administration moved marijuana into a category of drugs on par with Tylenol with codeine to increase research and access.
